 |
 |
Parkinson's Radio, This Friday 12 N EST Tomorrow 3/14/03 www.live365.com/stations/travelswparkinsons Tomorrow's show will be a good one. Live from the Capital Hilton and the annual meeting of ASENT. Three prominent scientists have agreed to speak to the radio audience on issues related to transversing the gap between discovery from science to treatments for Patients. Ken Marek MD.....an investigator for the Parkinson's Study Group and an expert on spect scans as markers of disease progression in PD will discuss his research and the issues around validation of surrogate biomarkers for evaluation of neuro protective treatments. He is working with both Cephalon and Guilford on their current trials. I will especially like to find out what data and research are necessary to establish surrogate markers and when he expects these markers will be accepted by FDA. Kitty Clarence Smith MD... President of ASENT and President of Prestwick Pharmaceuticals, a small biotech firm with Parkinson's drugs close to human trials, will describe ASENT's role in education of the public and professionals about drug development and clinical trials. She will describe the unique entreprenurial role of small companies with limited capital. Diane Murphy, PhD, Director of the Neurodegeneration cluster at the Neurology Institute NIH. and thus a key leader for PD research at NIH will describe Dr. Zerhouni's (NIH Director) initiative to make PD an example of disease oriented research at NIH. She will also introduce the upcoming neuroprotective trials sponsored by NIH. I will describe progress on getting a similar designation at FDA. Time permitting, I will introduce others at the meeting such as Lucy Sargent, new staff at PDF and if possible Nate Slewett, chair of NPF. (merger or not we have to work together to beat PD.) . Chy, get your recording equipment ready!!!!!!! This one will be quite informative. Perry Cohen ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn